The Amifostine Hydrate Market size is expected to grow at an annual average of 7% during 2022-2028. Amifostine hydrate is provided as a single dose vial of 500 mg for intravenous administration and must be reconstituted by injection of 9.7 ml sodium chloride (0.9%). The reconstituted mixture is stable for 5 hours at room temperature and 24 hours when stored in the refrigerator. It should be administered 30 minutes prior to chemotherapy, and blood pressure should be continuously monitored every 5 minutes during the infusion. The recommended dose to reduce cumulative nephrotoxicity is 910 mg/m2 15-minute infusion once daily, administered 30 minutes prior to chemotherapy, with continuous blood pressure monitoring every 5 minutes during the infusion. The recommended dose for dry mouth is 200 mg/m2 once daily, usually given 3 minutes before radiation therapy 15 minutes.
(Get 15% Discount on Buying this Report)
A full report of Amifostine Hydrate Market is available at: https://orionmarketreports.com/amifostine-hydrate-market/84824/
The following segmentation are covered in this report:
By Application
- Ovarian Cancer Adjuvant Therapy
- Head and Neck Cancer Adjuvant Therapy
- Others
By Type
- 400mg/Dose
- 500mg/Dose
Company Profile
- Clinigen Group
- Sun Pharmaceutical
- Taj Pharmaceuticals
- Merro Pharmaceutical
- Luye Pharma
- Mingren Pharma
The report covers the following objectives:
- Proliferation and maturation of trade in the global Amifostine Hydrate Market
- The market share of the global Amifostine Hydrate Market supply and demand ratio, growth revenue, supply chain analysis, and business overview.
- Current and future market trends that are influencing the growth opportunities and growth rate of the Amifostine Hydrate Market
- Feasibility study, new market insights, company profiles, investment return, revenue (value), and consumption (volume) of the global Amifostine Hydrate Market
Scope of the report
The research study analyses the Amifostine Hydrate Market industry from 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions, considering multiple aspects some of which are listed below as:
Recent developments
- Market overview and growth analysis
- Import and export overview
- Volume analysis
- Current market trends and future outlook
- Market opportunistic and attractive investment segment
Geographic coverage
- North america market size and/or volume
- Latin america market size and/or volume
- Europe market size and/or volume
- Asia-pacific market size and/or volume
- Rest of the world market size and/or volume
Key Questions Answered by Amifostine Hydrate Market Report
- What was the Amifostine Hydrate Market size in 2020 and 2021; what are the estimated growth trends and market forecast (2022-2028)
- What will be the CAGR of Market during the forecast period (2022-2028)?
- Which segments (product type/applications/end-user) were most attractive for investments in 2022? How these segments are expected to grow during the forecast period (2022-2028).
- Which manufacturer/vendor/players in the Amifostine Hydrate Market was the market leader in 2022?
- Overview on the existing product portfolio, products in the pipeline, and strategic initiatives taken by key vendors in the market.
About us:
Orion Market Reports (OMR) endeavors to provide exclusive blend of qualitative and quantitative market research reports to clients across the globe. Our organization helps both multinational and domestic enterprises to bolster their business by providing in-depth market insights and most reliable future market trends. Our reports address all the major aspects of the markets providing insights and market outlook to global clients.
Media Contact:
Company name: Orion Market Reports
Contact person: Mr. Anurag Tiwari
Email: info@orionmarketreports.com
Contact no: +91 780-304-0404
